| Title: | Comparative performance of multiple inflammatory indices across different stages of cardiovascular-kidney-metabolism syndrome: A Multi-Cohort Study |
| Journal: | Endocrine |
| Published: | 18 Aug 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/40825917/ |
| DOI: | https://doi.org/10.1007/s12020-025-04390-w |
Publication 16544
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundThis study investigated the associations between different inflammatory indices and mortality in CKM patients at various stages, with the goal of identifying the best inflammatory predictors of survival for each stage of CKM.Patients and methodsData from 18,700 representative CKM patients in NHANES 1999-2014 and 94,760 CKM patients from the UKB were analysed. The inflammatory index was calculated on the basis of the blood cell count and biochemical indicators. A multivariate Cox proportional hazards model was applied to analyse the associations between inflammatory indices and all-cause mortality stratified by CKM stage.ResultsThe advanced lung cancer inflammation index (ALI) has the best predictive performance for early CKM stages (NHANES: stage 2: AUC(t) = 0.600; stage 3: AUC(t) = 0.636; stage 4: AUC(t) = 0.678; UKB: stage 1: AUC(t) = 0.613; stage 3: AUC(t) = 0.666), with higher ALI levels correlated with lower all-cause mortality risk. In contrast, the monocyte-lymphocyte ratio (MLR), neutrophil-lymphocyte ratio (NLR), and systemic inflammation response index (SIRI) are correlated with an increased risk of all-cause mortality. The SIRI demonstrates superior predictive performance in the advanced stages of CKM.ConclusionThis study demonstrated that the ALI was negatively associated with all-cause mortality and exhibited optimal performance and robustness in predicting the prognosis of patients with early-stage CKM, whereas the SIRI showed superior predictive performance in the advanced stages of CKM.</p>
11 Authors
- Lingyuan Hu
- Zhuotong Wang
- Jiaqi Chen
- Aomiao Chen
- Geningyue Wang
- Xinran Xie
- Qiuyu He
- Yaoming Xue
- Zhiyong Wu
- Zongji Zheng
- Yijie Jia
1 Application
| Application ID | Title |
|---|---|
| 262612 | Causal studies of multiomics, genetics, lifestyle, and environmental factors on the progression and mortality of major common metabolic diseases |
Enabling scientific discoveries that improve human health